Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
News
$ 35.92
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Very low or no dividends
Data is available to registered users only
Data is available to registered users only
About
HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient's heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart's...
Target Price
The average target price of HTFL is 38 and suggests 6% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation sug
Data is available to registered users only
